SCHEMBL30847953

SCHEMBL30847953

FC(F)(F)c1cc(-n2cc(SCc3ccccc3)nn2)ccn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 5/20 0.49
▸ GRIN1 Q05586 5/20 0.49
▸ GRIN2B Q13224 5/20 0.49
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ MAPT P10636 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ PTGS2 P35354 1/20 0.39
▸ ALOX15B O15296 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ NPC1 O15118 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ NFKB2 Q00653 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ RELA Q04206 1/20 0.37
▸ LOXL2 Q9Y4K0 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27137524 1.00 RXRA (0.49) RXRAGRIN1GRIN2BCYP3A4CYP2C19
SCHEMBL27137528 0.78 PKM (0.40) RXRAGRIN1GRIN2BMAPTPKM
SCHEMBL15454013 0.74 LOXL2 (0.46) CYP3A4MAPTPKMPTGS2ALOX15B
SCHEMBL30016369 0.74 LOXL2 (0.46) CYP3A4MAPTPKMPTGS2ALOX15B
SCHEMBL19211469 0.72 NOTUM (0.63) RXRAGRIN1GRIN2BL3MBTL1NOTUM
SCHEMBL15454141 0.68 MAPT (0.61) MAPTPKMPTGS2ALOX15BL3MBTL1
SCHEMBL21614668 0.68 CYP3A4 (0.67) RXRAGRIN1GRIN2BCYP3A4CYP2C19
SCHEMBL31755983 0.68 RXRA (0.48) RXRAGRIN1GRIN2BNOTUM
SCHEMBL27137532 0.68 RXRA (0.48) RXRAGRIN1GRIN2BCYP3A4CYP2C19
SCHEMBL21614685 0.67 NOTUM (0.51) RXRAGRIN1GRIN2BCYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577536-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY Hotspot Therapeutics, Inc. (US) 2025-07-02 — — EP disclosed
WO-2024044730-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 — — WO disclosed
Send feedback